In summary, the present research, for the first time, revealed that circ-TLK1 is highly expressed in HCC samples and functions as an oncogene in HCC progression partly through competitively binding to miR-138-5p and then relieving the inhibitory effects on SOX4. This evidence concerns the gene SOX4 and hepatocellular carcinoma.